1035155-54-4 Usage
Benzene derivative
It is derived from benzene, a basic structure consisting of a six-carbon ring with alternating single and double bonds.
Bromine atom
A halogen atom (Br) is attached to one of the carbon atoms in the benzene ring.
Fluorine atoms
Two fluorine atoms (F) are attached to the benzene ring, providing unique reactivity and properties.
Benzyloxy group
A benzene ring with an attached oxygen atom (O) and a benzyl group (C6H5-CH2-), which is a phenylmethyl group.
Versatile reactivity
The compound can participate in various chemical reactions due to the presence of multiple functional groups.
Pharmaceutical research
It is used in the development of new drugs and pharmaceutical compounds.
Organic synthesis
The compound is utilized in the creation of complex organic molecules.
Toxicity
It can be toxic and harmful if not handled properly.
Controlled environments
It should be used and stored in controlled environments to minimize the risk of exposure and harm.
Proper management
Careful handling and safety precautions are necessary when working with this compound.
Check Digit Verification of cas no
The CAS Registry Mumber 1035155-54-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,5,1,5 and 5 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1035155-54:
(9*1)+(8*0)+(7*3)+(6*5)+(5*1)+(4*5)+(3*5)+(2*5)+(1*4)=114
114 % 10 = 4
So 1035155-54-4 is a valid CAS Registry Number.
1035155-54-4Relevant articles and documents
Tetrahydropyridino aromatic heterocyclic inhibitor as well as preparation method and application thereof
-
Paragraph 0120; 0122; 0123; 0124, (2021/02/10)
The invention discloses a hepatitis B virus surface antigen (HBsAg) secretion and HBV DNA generation inhibitor, provides a tetrahydropyridino aromatic heterocyclic compound with a structure shown in aformula (I), a stereoisomer, a tautomer or pharmaceutically acceptable salt, hydrate, solvate and prodrug thereof, and also provides a pharmaceutical composition of the pharmaceutically acceptable salt of the compound. The tetrahydropyridino aromatic heterocyclic compound can be used for treating and preventing viruses and related diseases.
TETRAHYDROPYRIDOPYRIMIDINES AND TETRAHYDROPYRIDOPYRIDINES AS INHIBITORS OF HBSAG (HBV SURFACE ANTIGEN) AND HBV DNA PRODUCTION FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTIONS
-
Page/Page column 83; 84, (2016/11/21)
The present invention provides tetrahydropyridopyrimidines and tetrahydropyridopyridines having the general formula (I) wherein R1, R2, U, W, X, Y and Z are as described herein, as inhibitors of HBsAg (HBV surface antigen) and HBV DNA production for the treatment and prophylaxis of hepatitis B virus infections.
